219 related articles for article (PubMed ID: 16427373)
1. Inhibitors to Factor XI in patients with severe Factor XI deficiency.
Salomon O; Zivelin A; Livnat T; Seligsohn U
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S10-2. PubMed ID: 16427373
[TBL] [Abstract][Full Text] [Related]
2. Factor XI deficiency.
O'connell NM
Semin Hematol; 2004 Jan; 41(1 Suppl 1):76-81. PubMed ID: 14872426
[TBL] [Abstract][Full Text] [Related]
3. Treatment of factor XI inhibitor using recombinant activated factor VIIa.
Bern MM; Sahud M; Zhukov O; Qu K; Mitchell W
Haemophilia; 2005 Jan; 11(1):20-5. PubMed ID: 15660984
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of recombinant activated factor VII: an update.
Hedner U
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S105-7. PubMed ID: 16427375
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
O'Connell NM; Riddell AF; Pascoe G; Perry DJ; Lee CA
Haemophilia; 2008 Jul; 14(4):775-81. PubMed ID: 18384352
[TBL] [Abstract][Full Text] [Related]
6. Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors.
Kenet G; Lubetsky A; Luboshitz J; Ravid B; Tamarin I; Varon D; Martinowitz U
Haemophilia; 2009 Sep; 15(5):1065-73. PubMed ID: 19486172
[TBL] [Abstract][Full Text] [Related]
7. Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery.
Riddell A; Abdul-Kadir R; Pollard D; Tuddenham E; Gomez K
Thromb Haemost; 2011 Sep; 106(3):521-7. PubMed ID: 21833443
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
Livnat T; Tamarin I; Mor Y; Winckler H; Horowitz Z; Korianski Y; Bar-Zakay B; Seligsohn U; Salomon O
Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468
[TBL] [Abstract][Full Text] [Related]
9. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
[TBL] [Abstract][Full Text] [Related]
10. The role of recombinant factor VIIa for obstetric block in women with severe factor XI deficiency.
Setty S; Reddell A; England A; Gomez K; Kadir R
Haemophilia; 2011 Nov; 17(6):906-9. PubMed ID: 21453421
[TBL] [Abstract][Full Text] [Related]
11. The Management of Factor XI Deficiency in Pregnancy.
Davies J; Kadir R
Semin Thromb Hemost; 2016 Oct; 42(7):732-740. PubMed ID: 27699729
[TBL] [Abstract][Full Text] [Related]
12. Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency.
Lawler P; White B; Pye S; Hermans C; Riddell A; Costello C; Brown S; Lee CA
Haemophilia; 2002 Mar; 8(2):145-8. PubMed ID: 11952851
[TBL] [Abstract][Full Text] [Related]
13. New observations on factor XI deficiency.
Salomon O; Seligsohn U
Haemophilia; 2004 Oct; 10 Suppl 4():184-7. PubMed ID: 15479396
[TBL] [Abstract][Full Text] [Related]
14. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with congenital factor XI deficiency.
Avci Z; Malbora B; Gokdemir M; Ozkan S; Ozbek N
Pediatr Cardiol; 2008 Jan; 29(1):220-2. PubMed ID: 17885783
[TBL] [Abstract][Full Text] [Related]
15. [Use of recombinant, activated Factor VII in the treatment and prevention of bleeding complications in two female patients suffering from congenital XI factor deficiency during orthopedic and traumatology intervention. Case reports].
Moravcsik B; Nemes L; Zsiros L
Orv Hetil; 2008 Aug; 149(33):1565-8. PubMed ID: 18687576
[TBL] [Abstract][Full Text] [Related]
16. Factor XI Deficiency.
Duga S; Salomon O
Semin Thromb Hemost; 2009 Jun; 35(4):416-25. PubMed ID: 19598070
[TBL] [Abstract][Full Text] [Related]
17. An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency.
Schulman S; Németh G
Haemophilia; 2006 May; 12(3):223-7. PubMed ID: 16643205
[TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa (Novoseven) as a hemostatic agent.
Hedner U
Semin Hematol; 2001 Oct; 38(4 Suppl 12):43-7. PubMed ID: 11735110
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated factor VII (rFVIIa, NovoSeven).
Agarwal MB; Patnaik M
J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
[TBL] [Abstract][Full Text] [Related]
20. Congenital factor XI deficiency: an update.
Duga S; Salomon O
Semin Thromb Hemost; 2013 Sep; 39(6):621-31. PubMed ID: 23929304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
